HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,125.00
+100.00 (2.48%)
At close: Aug 24, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 123.75 billion as of August 24, 2026. Its market cap has decreased by -10.23% in one year.
Market Cap
123.75B
Enterprise Value
112.96B
Revenue
135.04B
Ranking
n/a
PE Ratio
9.92
Stock Price
4,125.00
ChartMarket Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 123.75B, an increase of 387.15%. That is a compound annual growth rate of 6.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 123.75B | -3.96% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cosmax Nbt | 165.67B |
| CellBion | 165.06B |
| GC WellBeing | 151.01B |
| Kyung Dong Pharmaceutical | 136.06B |
| PHARMARESEARCH BIO | 131.48B |
| High Tech Pharm | 124.62B |
| Ahn-Gook Pharmaceutical | 117.86B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 117.08B |